Are liver function tests required before starting this treatment?
The provided information does not specify any liver function test (LFT) requirement (such as baseline AST/ALT, bilirubin, or alkaline phosphatase) before starting the therapy.
Are liver function tests required during treatment or only at baseline?
The provided information does not mention any on-treatment monitoring schedule for liver tests, so it’s not possible to confirm whether LFTs are required at baseline only, periodically during therapy, or if they are triggered only by symptoms.
What kinds of liver tests are typically monitored if LFTs are required?
When products require liver monitoring, it is usually framed around measuring:
- AST and ALT
- Total bilirubin (sometimes with direct/indirect bilirubin)
- Alkaline phosphatase and/or GGT
However, the specific tests that apply here depend on the exact medication and prescribing information, which were not included in the material provided.
What you can do next to get the right answer
If you share the drug name (and dose, if relevant), I can confirm whether its prescribing information requires:
- baseline LFTs,
- repeat LFTs during therapy,
- and any “stop/hold” thresholds.
Sources
No sources were provided in the question.